Clinical Trial Information
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS EFZOFITIMOD IN PATIENTS WITH PULMONARY SARCOIDOSIS
Protocol Number: 14964Status: OpenAge Group: AdultTreatment Type: TreatmentPhase: IIINCT ID: NCT05415137
Scope Information
Scope:
National
Disease Site(s):
Other
Contact Information
Facilitators
Principle Investigator: Daouk, SalimParticipating Institutions OU Health University of Oklahoma Medical Center; Oklahoma Clinical and Translational Science Institute; University of Oklahoma Health Sciences Center
Group Info
Management Group: CTSI-Oklahoma Clinical and Translational Science Institute; IM-Pulmonary, Critical Care, and Sleep Medicine
